The lung is a common site of complications of systemic connective tissue disease (CTD),
and lung involvement can present in several ways. Interstitial lung disease (ILD) and …

Antiphospholipid syndrome (APS) is the association of thrombosis and/or pregnancy
morbidity with antiphospholipid antibodies (aPL). Thirty to forty percent of systemic lupus …

Systemic lupus erythematosus (SLE) is an autoimmune rheumatic disease characterized by
the production of pathogenic autoantibodies and immune complexes and is responsible for …

Interstitial lung disease is a common pulmonary manifestation of connective tissue diseases
and results in significant morbidity and mortality. Although all connective tissue diseases are …

Pulmonary fibrosis, a serious complication of systemic lupus erythematosus (SLE) and
coronavirus disease 2019 (COVID-19), leads to irreversible lung damage. However, the …

Pulmonary Hypertension (PH) is a common manifestation in patients with Systemic Lupus
Erythematosus (SLE) and varies from asymptomatic to life-threatening disease. PH can …

Interstitial lung disease (ILD) is one of the most serious pulmonary complications of
connective tissue diseases (CTDs) and it is characterized by a deep impact on morbidity and …

Abstract Background Interstitial lung diseases (ILDs) are a heterogeneous group of
disorders characterized by inflammation and/or fibrosis of the lungs, varying from idiopathic …

Background The purpose of this study was to assess the prevalence, associated factors, and
impact on mortality of primary respiratory disease in a large systemic lupus erythematosus …

Shrinking lung syndrome (SLS) is a rare and less known complication mainly associated
with systemic lupus erythematosus (SLE). In this study, we analyze the clinical features …